Promoter methylation and silencing of PTEN in gastric carcinoma

Laboratory Investigation

Volumn 82, Issue 3, 2002, Pages 285-291

  Kang, Young Hwa ^a,b   Lee, Hye Seung ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b BK21 Project for Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA;

ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; CHROMOSOME 10; CONTROLLED STUDY; CPG ISLAND; EPITHELIUM CELL; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; METHYLATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, SIGNET RING CELL; DNA METHYLATION; DNA, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0036127525     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780422     Document Type: Article

References (36)

1. Alterations in DNA methylation: A fundamental aspect of neoplasia
2. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies
3. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
4. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies
5. PTEN, a unique tumor suppressor gene
6. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
7. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer
8. Hypermethylation of tumor suppressor genes in cancer
9. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
10. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression
11. CpG island methylation in premalignant stages of gastric carcinoma
12. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme
13. MUC1, MUC2 and p53 expression in gastric carcinoma: Their role as prognostic markers
14. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues
15. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
16. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
17. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
18. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
19. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
20. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
21. PTEN, the tumor suppressor from human chromosome 10q23, is a dual specificity phosphatase
22. PTEN/MMAC1 in malignant melanoma and its importance for tumor progression
23. PTEN gene mutations are seen in high-grade but not in low-grade gliomas
24. DNA methylation and gene regulation
25. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas
26. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics
27. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma
28. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
29. PTEN modulates cell cycle progression and cell survival by regulating phosphatydylinositol 3,4,5,-tirphosphate and AKT/protein kinase B signaling pathway
30. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
31. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies
32. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
33. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
34. PTEN controls tumor-induced angiogenesis
35. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
36. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation